APO Research
Talk to an analyst

APO RESEARCH · REPORT

Meropenem Powder Injection

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Meropenem Powder Injection Market Outlook and Growth Opportunities 2026

27 December 2025198 pages

Choose your research edition.

Industry ResearchMeropenem Powder Injection Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Meropenem Powder Injection Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Meropenem Powder Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Meropenem Powder Injection Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Meropenem Powder Injection Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Meropenem Powder Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Meropenem Powder Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Meropenem Powder Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Meropenem Powder Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Meropenem Powder Injection market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Meropenem Powder Injection market include Chongqing Shenghuaxi Pharma, Haikou Pharmaceutical Factory, Luoxin Pharna, Hisun, Shanghai Pharma, United Laboratories, Sumitomo Pharma, PKU HealthCare and Pfizer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Meropenem Powder Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Meropenem Powder Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Meropenem Powder Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Meropenem Powder Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Meropenem Powder Injection Segment by Company

Chongqing Shenghuaxi Pharma

Haikou Pharmaceutical Factory

Luoxin Pharna

Hisun

Shanghai Pharma

United Laboratories

Sumitomo Pharma

PKU HealthCare

Pfizer

Joincare

Intelicure Lifesciences

CSPC Pharmaceutical Group

Meropenem Powder Injection Segment by Type

1.0g per Vial

0.50g per Vial

0.25g per Vial

Meropenem Powder Injection Segment by Application

Skin and Soft Tissue Infections（SSTI）

Meningitis

Urinary Tract Infection

Gynecological Infections

Septicemia

Other

Meropenem Powder Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Meropenem Powder Injection status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Meropenem Powder Injection market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Meropenem Powder Injection significant trends, drivers, influence factors in global and regions.

6. To analyze Meropenem Powder Injection competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Meropenem Powder Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Meropenem Powder Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Meropenem Powder Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Meropenem Powder Injection market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Meropenem Powder Injection industry.

Chapter 3: Detailed analysis of Meropenem Powder Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Meropenem Powder Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Meropenem Powder Injection in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Meropenem Powder Injection Industry Trends Table 2. Meropenem Powder Injection Industry Drivers Table 3. Meropenem Powder Injection Industry Opportunities and Challenges Table 4. Meropenem Powder Injection Industry Restraints Table 5. Global Meropenem Powder Injection Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Meropenem Powder Injection Revenue Share by Company (2021-2026) Table 7. Global Meropenem Powder Injection Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Meropenem Powder Injection Sales Volume Share by Company (2021-2026) Table 9. Global Meropenem Powder Injection Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Meropenem Powder Injection Company Ranking, (2024-2026) & (USD Million) Table 11. Global Meropenem Powder Injection Key Company Manufacturing Base & Headquarters Table 12. Global Meropenem Powder Injection Company, Product Type & Application Table 13. Global Meropenem Powder Injection Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Meropenem Powder Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 1.0g per Vial Table 18. Significant Companies of 0.50g per Vial Table 19. Significant Companies of 0.25g per Vial Table 20. Global Meropenem Powder Injection Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Meropenem Powder Injection Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Meropenem Powder Injection Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Meropenem Powder Injection Sales Volume Share by Type (2021-2026) Table 24. Global Meropenem Powder Injection Sales Volume Share by Type (2027-2032) Table 25. Global Meropenem Powder Injection Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Meropenem Powder Injection Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Meropenem Powder Injection Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Meropenem Powder Injection Sales Value Share by Type (2021-2026) Table 29. Global Meropenem Powder Injection Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Skin and Soft Tissue Infections（SSTI） Table 31. Significant Companies of Meningitis Table 32. Significant Companies of Urinary Tract Infection Table 33. Significant Companies of Gynecological Infections Table 34. Significant Companies of Septicemia Table 35. Significant Companies of Other Table 36. Global Meropenem Powder Injection Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Meropenem Powder Injection Sales Volume by Application (2021-2026) & (K Units) Table 38. Global Meropenem Powder Injection Sales Volume by Application (2027-2032) & (K Units) Table 39. Global Meropenem Powder Injection Sales Volume Share by Application (2021-2026) Table 40. Global Meropenem Powder Injection Sales Volume Share by Application (2027-2032) Table 41. Global Meropenem Powder Injection Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 42. Global Meropenem Powder Injection Sales Value by Application (2021-2026) & (US$ Million) Table 43. Global Meropenem Powder Injection Sales Value by Application (2027-2032) & (US$ Million) Table 44. Global Meropenem Powder Injection Sales Value Share by Application (2021-2026) Table 45. Global Meropenem Powder Injection Sales Value Share by Application (2027-2032) Table 46. Global Meropenem Powder Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 47. Global Meropenem Powder Injection Sales by Region (2021-2026) & (K Units) Table 48. Global Meropenem Powder Injection Sales Market Share by Region (2021-2026) Table 49. Global Meropenem Powder Injection Sales by Region (2027-2032) & (K Units) Table 50. Global Meropenem Powder Injection Sales Market Share by Region (2027-2032) Table 51. Global Meropenem Powder Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 52. Global Meropenem Powder Injection Sales Value by Region (2021-2026) & (US$ Million) Table 53. Global Meropenem Powder Injection Sales Value Share by Region (2021-2026) Table 54. Global Meropenem Powder Injection Sales Value by Region (2027-2032) & (US$ Million) Table 55. Global Meropenem Powder Injection Sales Value Share by Region (2027-2032) Table 56. Global Meropenem Powder Injection Market Average Price (US$/Unit) by Region (2021-2026) Table 57. Global Meropenem Powder Injection Market Average Price (US$/Unit) by Region (2027-2032) Table 58. Global Meropenem Powder Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 59. Global Meropenem Powder Injection Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Meropenem Powder Injection Sales by Country (2021-2026) & (K Units) Table 61. Global Meropenem Powder Injection Sales Market Share by Country (2021-2026) Table 62. Global Meropenem Powder Injection Sales by Country (2027-2032) & (K Units) Table 63. Global Meropenem Powder Injection Sales Market Share by Country (2027-2032) Table 64. Global Meropenem Powder Injection Sales Value by Country (2021-2026) & (US$ Million) Table 65. Global Meropenem Powder Injection Sales Value Market Share by Country (2021-2026) Table 66. Global Meropenem Powder Injection Sales Value by Country (2027-2032) & (US$ Million) Table 67. Global Meropenem Powder Injection Sales Value Market Share by Country (2027-2032) Table 68. Chongqing Shenghuaxi Pharma Company Information Table 69. Chongqing Shenghuaxi Pharma Business Overview Table 70. Chongqing Shenghuaxi Pharma Meropenem Powder Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Chongqing Shenghuaxi Pharma Meropenem Powder Injection Product Portfolio Table 72. Chongqing Shenghuaxi Pharma Recent Development Table 73. Haikou Pharmaceutical Factory Company Information Table 74. Haikou Pharmaceutical Factory Business Overview Table 75. Haikou Pharmaceutical Factory Meropenem Powder Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Haikou Pharmaceutical Factory Meropenem Powder Injection Product Portfolio Table 77. Haikou Pharmaceutical Factory Recent Development Table 78. Luoxin Pharna Company Information Table 79. Luoxin Pharna Business Overview Table 80. Luoxin Pharna Meropenem Powder Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Luoxin Pharna Meropenem Powder Injection Product Portfolio Table 82. Luoxin Pharna Recent Development Table 83. Hisun Company Information Table 84. Hisun Business Overview Table 85. Hisun Meropenem Powder Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Hisun Meropenem Powder Injection Product Portfolio Table 87. Hisun Recent Development Table 88. Shanghai Pharma Company Information Table 89. Shanghai Pharma Business Overview Table 90. Shanghai Pharma Meropenem Powder Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Shanghai Pharma Meropenem Powder Injection Product Portfolio Table 92. Shanghai Pharma Recent Development Table 93. United Laboratories Company Information Table 94. United Laboratories Business Overview Table 95. United Laboratories Meropenem Powder Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. United Laboratories Meropenem Powder Injection Product Portfolio Table 97. United Laboratories Recent Development Table 98. Sumitomo Pharma Company Information Table 99. Sumitomo Pharma Business Overview Table 100. Sumitomo Pharma Meropenem Powder Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Sumitomo Pharma Meropenem Powder Injection Product Portfolio Table 102. Sumitomo Pharma Recent Development Table 103. PKU HealthCare Company Information Table 104. PKU HealthCare Business Overview Table 105. PKU HealthCare Meropenem Powder Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. PKU HealthCare Meropenem Powder Injection Product Portfolio Table 107. PKU HealthCare Recent Development Table 108. Pfizer Company Information Table 109. Pfizer Business Overview Table 110. Pfizer Meropenem Powder Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Pfizer Meropenem Powder Injection Product Portfolio Table 112. Pfizer Recent Development Table 113. Joincare Company Information Table 114. Joincare Business Overview Table 115. Joincare Meropenem Powder Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Joincare Meropenem Powder Injection Product Portfolio Table 117. Joincare Recent Development Table 118. Intelicure Lifesciences Company Information Table 119. Intelicure Lifesciences Business Overview Table 120. Intelicure Lifesciences Meropenem Powder Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Intelicure Lifesciences Meropenem Powder Injection Product Portfolio Table 122. Intelicure Lifesciences Recent Development Table 123. CSPC Pharmaceutical Group Company Information Table 124. CSPC Pharmaceutical Group Business Overview Table 125. CSPC Pharmaceutical Group Meropenem Powder Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. CSPC Pharmaceutical Group Meropenem Powder Injection Product Portfolio Table 127. CSPC Pharmaceutical Group Recent Development Table 128. Key Raw Materials Table 129. Raw Materials Key Suppliers Table 130. Meropenem Powder Injection Distributors List Table 131. Meropenem Powder Injection Customers List Table 132. Research Programs/Design for This Report Table 133. Authors List of This Report Table 134. Secondary Sources Table 135. Primary Sources List of Figures Figure 1. Meropenem Powder Injection Product Image Figure 2. Global Meropenem Powder Injection Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Meropenem Powder Injection Sales Value (2021-2032) & (US$ Million) Figure 4. Global Meropenem Powder Injection Sales (2021-2032) & (K Units) Figure 5. Global Meropenem Powder Injection Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Meropenem Powder Injection Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 1.0g per Vial Image Figure 10. 0.50g per Vial Image Figure 11. 0.25g per Vial Image Figure 12. Global Meropenem Powder Injection Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Meropenem Powder Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Meropenem Powder Injection Sales Volume Share by Type (2021-2032) Figure 15. Global Meropenem Powder Injection Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Meropenem Powder Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Meropenem Powder Injection Sales Value Share by Type (2021-2032) Figure 18. Skin and Soft Tissue Infections（SSTI） Image Figure 19. Meningitis Image Figure 20. Urinary Tract Infection Image Figure 21. Gynecological Infections Image Figure 22. Septicemia Image Figure 23. Other Image Figure 24. Global Meropenem Powder Injection Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Meropenem Powder Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 26. Global Meropenem Powder Injection Sales Volume Share by Application (2021-2032) Figure 27. Global Meropenem Powder Injection Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Meropenem Powder Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 29. Global Meropenem Powder Injection Sales Value Share by Application (2021-2032) Figure 30. Global Meropenem Powder Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 31. Global Meropenem Powder Injection Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 32. Global Meropenem Powder Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 33. Global Meropenem Powder Injection Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 34. North America Meropenem Powder Injection Sales Value (2021-2032) & (US$ Million) Figure 35. North America Meropenem Powder Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Europe Meropenem Powder Injection Sales Value (2021-2032) & (US$ Million) Figure 37. Europe Meropenem Powder Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Asia-Pacific Meropenem Powder Injection Sales Value (2021-2032) & (US$ Million) Figure 39. Asia-Pacific Meropenem Powder Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 40. South America Meropenem Powder Injection Sales Value (2021-2032) & (US$ Million) Figure 41. South America Meropenem Powder Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 42. Middle East & Africa Meropenem Powder Injection Sales Value (2021-2032) & (US$ Million) Figure 43. Middle East & Africa Meropenem Powder Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 44. USA Meropenem Powder Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. USA Meropenem Powder Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. USA Meropenem Powder Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Canada Meropenem Powder Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Canada Meropenem Powder Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Canada Meropenem Powder Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Mexico Meropenem Powder Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Mexico Meropenem Powder Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Mexico Meropenem Powder Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Germany Meropenem Powder Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Germany Meropenem Powder Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Germany Meropenem Powder Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. France Meropenem Powder Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. France Meropenem Powder Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. France Meropenem Powder Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. U.K. Meropenem Powder Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. U.K. Meropenem Powder Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. U.K. Meropenem Powder Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Italy Meropenem Powder Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Italy Meropenem Powder Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Italy Meropenem Powder Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Spain Meropenem Powder Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Spain Meropenem Powder Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Spain Meropenem Powder Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Russia Meropenem Powder Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Russia Meropenem Powder Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Russia Meropenem Powder Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Netherlands Meropenem Powder Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Netherlands Meropenem Powder Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Netherlands Meropenem Powder Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Nordic Countries Meropenem Powder Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Nordic Countries Meropenem Powder Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Nordic Countries Meropenem Powder Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. China Meropenem Powder Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. China Meropenem Powder Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. China Meropenem Powder Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Japan Meropenem Powder Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Japan Meropenem Powder Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Japan Meropenem Powder Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. South Korea Meropenem Powder Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. South Korea Meropenem Powder Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. South Korea Meropenem Powder Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. India Meropenem Powder Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. India Meropenem Powder Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. India Meropenem Powder Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Australia Meropenem Powder Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Australia Meropenem Powder Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Australia Meropenem Powder Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Southeast Asia Meropenem Powder Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Southeast Asia Meropenem Powder Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Southeast Asia Meropenem Powder Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Brazil Meropenem Powder Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Brazil Meropenem Powder Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Brazil Meropenem Powder Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Argentina Meropenem Powder Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Argentina Meropenem Powder Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Argentina Meropenem Powder Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Chile Meropenem Powder Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Chile Meropenem Powder Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Chile Meropenem Powder Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Colombia Meropenem Powder Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Colombia Meropenem Powder Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Colombia Meropenem Powder Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Peru Meropenem Powder Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Peru Meropenem Powder Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Peru Meropenem Powder Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Meropenem Powder Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Saudi Arabia Meropenem Powder Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Saudi Arabia Meropenem Powder Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Israel Meropenem Powder Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Israel Arabia Meropenem Powder Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Israel Arabia Meropenem Powder Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. UAE Meropenem Powder Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. UAE Meropenem Powder Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. UAE Meropenem Powder Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Turkey Meropenem Powder Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Turkey Meropenem Powder Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Turkey Meropenem Powder Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Iran Meropenem Powder Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Iran Meropenem Powder Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Iran Meropenem Powder Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Egypt Meropenem Powder Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 126. Egypt Meropenem Powder Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 127. Egypt Meropenem Powder Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 128. Meropenem Powder Injection Value Chain Figure 129. Manufacturing Cost Structure Figure 130. Meropenem Powder Injection Sales Mode & Process Figure 131. Direct Comparison with Distribution Share Figure 132. Distributors Profiles Figure 133. Years Considered Figure 134. Research Process Figure 135. Key Executives Interviewed

Scope & coverage.

Types
  • 1.0g per Vial
  • 0.50g per Vial
  • 0.25g per Vial
Applications
  • Skin and Soft Tissue Infections（SSTI）
  • Meningitis
  • Urinary Tract Infection
  • Gynecological Infections
  • Septicemia
  • Other
Companies covered
  • Chongqing Shenghuaxi Pharma
  • Haikou Pharmaceutical Factory
  • Luoxin Pharna
  • Hisun
  • Shanghai Pharma
  • United Laboratories
  • Sumitomo Pharma
  • PKU HealthCare
  • Pfizer
  • Joincare
  • Intelicure Lifesciences
  • CSPC Pharmaceutical Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Meropenem Powder Injection Sales Value (2021-2032)
  4. 1.2.2 Global Meropenem Powder Injection Sales Volume (2021-2032)
  5. 1.2.3 Global Meropenem Powder Injection Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Meropenem Powder Injection Market Dynamics
  1. 2.1 Meropenem Powder Injection Industry Trends
  2. 2.2 Meropenem Powder Injection Industry Drivers
  3. 2.3 Meropenem Powder Injection Industry Opportunities and Challenges
  4. 2.4 Meropenem Powder Injection Industry Restraints
3 Meropenem Powder Injection Market by Company
  1. 3.1 Global Meropenem Powder Injection Company Revenue Ranking in 2025
  2. 3.2 Global Meropenem Powder Injection Revenue by Company (2021-2026)
  3. 3.3 Global Meropenem Powder Injection Sales Volume by Company (2021-2026)
  4. 3.4 Global Meropenem Powder Injection Average Price by Company (2021-2026)
  5. 3.5 Global Meropenem Powder Injection Company Ranking (2024-2026)
  6. 3.6 Global Meropenem Powder Injection Company Manufacturing Base and Headquarters
  7. 3.7 Global Meropenem Powder Injection Company Product Type and Application
  8. 3.8 Global Meropenem Powder Injection Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Meropenem Powder Injection Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Meropenem Powder Injection Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Meropenem Powder Injection Market by Type
  1. 4.1 Meropenem Powder Injection Type Introduction
  2. 4.1.1 1.0g per Vial
  3. 4.1.2 0.50g per Vial
  4. 4.1.3 0.25g per Vial
  5. 4.2 Global Meropenem Powder Injection Sales Volume by Type
  6. 4.2.1 Global Meropenem Powder Injection Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Meropenem Powder Injection Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Meropenem Powder Injection Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Meropenem Powder Injection Sales Value by Type
  10. 4.3.1 Global Meropenem Powder Injection Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Meropenem Powder Injection Sales Value by Type (2021-2032)
  12. 4.3.3 Global Meropenem Powder Injection Sales Value Share by Type (2021-2032)
5 Meropenem Powder Injection Market by Application
  1. 5.1 Meropenem Powder Injection Application Introduction
  2. 5.1.1 Skin and Soft Tissue Infections（SSTI）
  3. 5.1.2 Meningitis
  4. 5.1.3 Urinary Tract Infection
  5. 5.1.4 Gynecological Infections
  6. 5.1.5 Septicemia
  7. 5.1.6 Other
  8. 5.2 Global Meropenem Powder Injection Sales Volume by Application
  9. 5.2.1 Global Meropenem Powder Injection Sales Volume by Application (2021 VS 2025 VS 2032)
  10. 5.2.2 Global Meropenem Powder Injection Sales Volume by Application (2021-2032)
  11. 5.2.3 Global Meropenem Powder Injection Sales Volume Share by Application (2021-2032)
  12. 5.3 Global Meropenem Powder Injection Sales Value by Application
  13. 5.3.1 Global Meropenem Powder Injection Sales Value by Application (2021 VS 2025 VS 2032)
  14. 5.3.2 Global Meropenem Powder Injection Sales Value by Application (2021-2032)
  15. 5.3.3 Global Meropenem Powder Injection Sales Value Share by Application (2021-2032)
6 Meropenem Powder Injection Regional Sales and Value Analysis
  1. 6.1 Global Meropenem Powder Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Meropenem Powder Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Meropenem Powder Injection Sales by Region: 2021-2026
  4. 6.2.2 Global Meropenem Powder Injection Sales by Region (2027-2032)
  5. 6.3 Global Meropenem Powder Injection Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Meropenem Powder Injection Sales Value by Region (2021-2032)
  7. 6.4.1 Global Meropenem Powder Injection Sales Value by Region: 2021-2026
  8. 6.4.2 Global Meropenem Powder Injection Sales Value by Region (2027-2032)
  9. 6.5 Global Meropenem Powder Injection Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Meropenem Powder Injection Sales Value (2021-2032)
  12. 6.6.2 North America Meropenem Powder Injection Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Meropenem Powder Injection Sales Value (2021-2032)
  15. 6.7.2 Europe Meropenem Powder Injection Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Meropenem Powder Injection Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Meropenem Powder Injection Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Meropenem Powder Injection Sales Value (2021-2032)
  21. 6.9.2 South America Meropenem Powder Injection Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Meropenem Powder Injection Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Meropenem Powder Injection Sales Value Share by Country, 2025 VS 2032
7 Meropenem Powder Injection Country-level Sales and Value Analysis
  1. 7.1 Global Meropenem Powder Injection Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Meropenem Powder Injection Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Meropenem Powder Injection Sales by Country (2021-2032)
  4. 7.3.1 Global Meropenem Powder Injection Sales by Country (2021-2026)
  5. 7.3.2 Global Meropenem Powder Injection Sales by Country (2027-2032)
  6. 7.4 Global Meropenem Powder Injection Sales Value by Country (2021-2032)
  7. 7.4.1 Global Meropenem Powder Injection Sales Value by Country (2021-2026)
  8. 7.4.2 Global Meropenem Powder Injection Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Meropenem Powder Injection Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Meropenem Powder Injection Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Meropenem Powder Injection Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Meropenem Powder Injection Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Meropenem Powder Injection Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Meropenem Powder Injection Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Meropenem Powder Injection Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Meropenem Powder Injection Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Meropenem Powder Injection Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Meropenem Powder Injection Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Meropenem Powder Injection Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Meropenem Powder Injection Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Meropenem Powder Injection Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Meropenem Powder Injection Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Meropenem Powder Injection Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Meropenem Powder Injection Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Meropenem Powder Injection Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Meropenem Powder Injection Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Meropenem Powder Injection Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Meropenem Powder Injection Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Meropenem Powder Injection Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Meropenem Powder Injection Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Meropenem Powder Injection Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Meropenem Powder Injection Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Meropenem Powder Injection Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Meropenem Powder Injection Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Meropenem Powder Injection Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Meropenem Powder Injection Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Meropenem Powder Injection Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Meropenem Powder Injection Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Meropenem Powder Injection Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Meropenem Powder Injection Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Meropenem Powder Injection Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Meropenem Powder Injection Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Meropenem Powder Injection Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Meropenem Powder Injection Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Meropenem Powder Injection Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Meropenem Powder Injection Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Meropenem Powder Injection Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Meropenem Powder Injection Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Meropenem Powder Injection Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Meropenem Powder Injection Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Meropenem Powder Injection Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Meropenem Powder Injection Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Meropenem Powder Injection Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Meropenem Powder Injection Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Meropenem Powder Injection Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Meropenem Powder Injection Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Meropenem Powder Injection Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Meropenem Powder Injection Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Meropenem Powder Injection Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Meropenem Powder Injection Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Meropenem Powder Injection Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Meropenem Powder Injection Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Meropenem Powder Injection Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Meropenem Powder Injection Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Meropenem Powder Injection Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Meropenem Powder Injection Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Meropenem Powder Injection Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Meropenem Powder Injection Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Meropenem Powder Injection Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Meropenem Powder Injection Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Meropenem Powder Injection Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Meropenem Powder Injection Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Meropenem Powder Injection Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Meropenem Powder Injection Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Meropenem Powder Injection Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Meropenem Powder Injection Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Meropenem Powder Injection Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Meropenem Powder Injection Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Meropenem Powder Injection Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Meropenem Powder Injection Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Meropenem Powder Injection Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Meropenem Powder Injection Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Meropenem Powder Injection Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Meropenem Powder Injection Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Meropenem Powder Injection Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Meropenem Powder Injection Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Meropenem Powder Injection Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Meropenem Powder Injection Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Meropenem Powder Injection Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Meropenem Powder Injection Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Meropenem Powder Injection Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Meropenem Powder Injection Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Chongqing Shenghuaxi Pharma
  2. 8.1.1 Chongqing Shenghuaxi Pharma Company Information
  3. 8.1.2 Chongqing Shenghuaxi Pharma Business Overview
  4. 8.1.3 Chongqing Shenghuaxi Pharma Meropenem Powder Injection Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Chongqing Shenghuaxi Pharma Meropenem Powder Injection Product Portfolio
  6. 8.1.5 Chongqing Shenghuaxi Pharma Recent Developments
  7. 8.2 Haikou Pharmaceutical Factory
  8. 8.2.1 Haikou Pharmaceutical Factory Company Information
  9. 8.2.2 Haikou Pharmaceutical Factory Business Overview
  10. 8.2.3 Haikou Pharmaceutical Factory Meropenem Powder Injection Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Haikou Pharmaceutical Factory Meropenem Powder Injection Product Portfolio
  12. 8.2.5 Haikou Pharmaceutical Factory Recent Developments
  13. 8.3 Luoxin Pharna
  14. 8.3.1 Luoxin Pharna Company Information
  15. 8.3.2 Luoxin Pharna Business Overview
  16. 8.3.3 Luoxin Pharna Meropenem Powder Injection Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Luoxin Pharna Meropenem Powder Injection Product Portfolio
  18. 8.3.5 Luoxin Pharna Recent Developments
  19. 8.4 Hisun
  20. 8.4.1 Hisun Company Information
  21. 8.4.2 Hisun Business Overview
  22. 8.4.3 Hisun Meropenem Powder Injection Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Hisun Meropenem Powder Injection Product Portfolio
  24. 8.4.5 Hisun Recent Developments
  25. 8.5 Shanghai Pharma
  26. 8.5.1 Shanghai Pharma Company Information
  27. 8.5.2 Shanghai Pharma Business Overview
  28. 8.5.3 Shanghai Pharma Meropenem Powder Injection Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Shanghai Pharma Meropenem Powder Injection Product Portfolio
  30. 8.5.5 Shanghai Pharma Recent Developments
  31. 8.6 United Laboratories
  32. 8.6.1 United Laboratories Company Information
  33. 8.6.2 United Laboratories Business Overview
  34. 8.6.3 United Laboratories Meropenem Powder Injection Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 United Laboratories Meropenem Powder Injection Product Portfolio
  36. 8.6.5 United Laboratories Recent Developments
  37. 8.7 Sumitomo Pharma
  38. 8.7.1 Sumitomo Pharma Company Information
  39. 8.7.2 Sumitomo Pharma Business Overview
  40. 8.7.3 Sumitomo Pharma Meropenem Powder Injection Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Sumitomo Pharma Meropenem Powder Injection Product Portfolio
  42. 8.7.5 Sumitomo Pharma Recent Developments
  43. 8.8 PKU HealthCare
  44. 8.8.1 PKU HealthCare Company Information
  45. 8.8.2 PKU HealthCare Business Overview
  46. 8.8.3 PKU HealthCare Meropenem Powder Injection Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 PKU HealthCare Meropenem Powder Injection Product Portfolio
  48. 8.8.5 PKU HealthCare Recent Developments
  49. 8.9 Pfizer
  50. 8.9.1 Pfizer Company Information
  51. 8.9.2 Pfizer Business Overview
  52. 8.9.3 Pfizer Meropenem Powder Injection Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Pfizer Meropenem Powder Injection Product Portfolio
  54. 8.9.5 Pfizer Recent Developments
  55. 8.10 Joincare
  56. 8.10.1 Joincare Company Information
  57. 8.10.2 Joincare Business Overview
  58. 8.10.3 Joincare Meropenem Powder Injection Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Joincare Meropenem Powder Injection Product Portfolio
  60. 8.10.5 Joincare Recent Developments
  61. 8.11 Intelicure Lifesciences
  62. 8.11.1 Intelicure Lifesciences Company Information
  63. 8.11.2 Intelicure Lifesciences Business Overview
  64. 8.11.3 Intelicure Lifesciences Meropenem Powder Injection Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Intelicure Lifesciences Meropenem Powder Injection Product Portfolio
  66. 8.11.5 Intelicure Lifesciences Recent Developments
  67. 8.12 CSPC Pharmaceutical Group
  68. 8.12.1 CSPC Pharmaceutical Group Company Information
  69. 8.12.2 CSPC Pharmaceutical Group Business Overview
  70. 8.12.3 CSPC Pharmaceutical Group Meropenem Powder Injection Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 CSPC Pharmaceutical Group Meropenem Powder Injection Product Portfolio
  72. 8.12.5 CSPC Pharmaceutical Group Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Meropenem Powder Injection Value Chain Analysis
  2. 9.1.1 Meropenem Powder Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Meropenem Powder Injection Sales Mode & Process
  6. 9.2 Meropenem Powder Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Meropenem Powder Injection Distributors
  9. 9.2.3 Meropenem Powder Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst